WVXU: Meet the UC doctor trying to change minds skeptical of the COVID-19 vaccine
Louito Edje, MD, says the COVID-19 vaccine is based on years of science
Louito Edje, MD, associate dean of graduate medical education at the University of Cincinnati College of Medicine and UC Medical Center, spoke with WVXU about why she is on a public relations blitz – she was featured in segments on CNBC, TMZ, BET and MSNBC - to change minds about vaccinations for COVID-19. The pandemic is having a disproportionate impact on Black Americans and Edje, a Black female physician, is hoping her participation in the Moderna vaccine trial and her voice may sway some opinions about vaccine safety and efficacy.
After her second dose, Edje was pretty sure she didn’t get a placebo as part of the vaccine trial. "I had a lead arm and it lasted about 24 hours and not much longer than that," Edje told WVXU listeners. "I was able to continue working." She feels fine now and says the risk of being in a trial group was worth it to her because she's lost four family members to COVID-19.
Listen to the WVXU interview with Louito Edje, MD, online.
Louito Edje, MD, seated is shown in the UC College of Medicine Simulation Center. Photo by Colleen Kelley/University of Cincinnati.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.